Mitochondrial substrates in cancer: Drivers or passengers?

Mitochondrion

Volumn 19, Issue Part A, 2014, Pages 8-19

  Kruspig, Björn ^a   Zhivotovsky, Boris ^a,b   Gogvadze, Vladimir ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Cancer; Cell death; Metabolism; Mitochondria; Therapy; Warburg Effect

Indexed keywords

2 HYDROXYGLUTARIC ACID; 2 OXOGLUTARIC ACID; CITRIC ACID; GLUTAMINE; PYRUVIC ACID; SUCCINIC ACID; ANTINEOPLASTIC AGENT;

AEROBIC METABOLISM; AMINO ACID METABOLISM; AMINO ACID TRANSPORT; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER THERAPY; CARCINOGENESIS; CELL ENERGY; CELL PROLIFERATION; DRUG TARGETING; GLYCOLYSIS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; DRUG EFFECTS; ENERGY METABOLISM; METABOLISM; MITOCHONDRION; NEOPLASMS; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; ENERGY METABOLISM; HUMANS; MITOCHONDRIA; NEOPLASMS;

EID: 84911455934     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2014.08.007     Document Type: Article

References (170)

1. Ahluwalia G.S., Grem J.L., Hao Z., Cooney D.A. Metabolism and action of amino acid analog anti-cancer agents. Pharmacol. Ther. 1990, 46:243-271.
2. Albayrak T., Scherhammer V., Schoenfeld N., Braziulis E., Mund T., Bauer M.K.A., Scheffler I.E., Grimm S. The tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis induction. Mol. Biol. Cell 2003, 14:3082-3096.
3. Aledo J.C., Gomez-Fabre P.M., Olalla L., Marquez J. Identification of two human glutaminase loci and tissue-specific expression of the two related genes. Mamm. Genome 2000, 11:1107-1110.
4. Andronesi O.C., Kim G.S., Gerstner E., Batchelor T., Tzika A.A., Fantin V.R., Vander Heiden M.G., Sorensen A.G. Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy. Sci. Transl. Med. 2012, 4:116ra114.
5. Astuti D., Douglas F., Lennard T.W., Aligianis I.A., Woodward E.R., Evans D.G., Eng C., Latif F., Maher E.R. Germline SDHD mutation in familial phaeochromocytoma. Lancet 2001, 357:1181-1182.
6. Astuti D., Latif F., Dallol A., Dahia P.L., Douglas F., George E., Skoldberg F., Husebye E.S., Eng C., Maher E.R. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet. 2001, 69:49-54.
7. Bauer D.E., Hatzivassiliou G., Zhao F., Andreadis C., Thompson C.B. ATP citrate lyase is an important component of cell growth and transformation. Oncogene 2005, 24:6314-6322.
8. Baysal B.E. On the association of succinate dehydrogenase mutations with hereditary paraganglioma. Trends Endocrinol. Metab. 2003, 14:453-459.
9. Baysal B.E., Ferrell R.E., Willett-Brozick J.E., Lawrence E.C., Myssiorek D., Bosch A., van der Mey A., Taschner P.E., Rubinstein W.S., Myers E.N., Richard C.W., Cornelisse C.J., Devilee P., Devlin B. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000, 287:848-851.
10. Bisaccia F., De Palma A., Palmieri F. Identification and purification of the tricarboxylate carrier from rat liver mitochondria. Biochim. Biophys. Acta 1989, 977:171-176.
11. Bluemlein K., Gruning N.M., Feichtinger R.G., Lehrach H., Kofler B., Ralser M. No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis. Oncotarget 2011, 2:393-400.
12. Boatright K.M., Renatus M., Scott F.L., Sperandio S., Shin H., Pedersen I.M., Ricci J.E., Edris W.A., Sutherlin D.P., Green D.R., Salvesen G.S. A unified model for apical caspase activation. Mol. Cell 2003, 11:529-541.
13. Bucay A.H. Clinical report: a patient with primary peritoneal mesothelioma that has improved after taking citric acid orally. Clin. Res. Hepatol. Gastroenterol. 2011, 35:241.
14. Cardaci S., Rizza S., Filomeni G., Bernardini R., Bertocchi F., Mattei M., Paci M., Rotilio G., Ciriolo M.R. Glutamine deprivation enhances antitumor activity of 3-bromopyruvate through the stabilization of monocarboxylate transporter-1. Cancer Res. 2012, 72:4526-4536.
15. Carini R., Poli G., Dianzani M.U., Maddix S.P., Slater T.F., Cheeseman K.H. Comparative evaluation of the antioxidant activity of alpha-tocopherol, alpha-tocopherol polyethylene glycol 1000 succinate and alpha-tocopherol succinate in isolated hepatocytes and liver microsomal suspensions. Biochem. Pharmacol. 1990, 39:1597-1601.
16. Catalina-Rodriguez O., Kolukula V.K., Tomita Y., Preet A., Palmieri F., Wellstein A., Byers S., Giaccia A.J., Glasgow E., Albanese C., Avantaggiati M.L. The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis. Oncotarget 2012, 3:1220-1235.
17. Chance B., Hollunger G. The interaction of energy and electron transfer reactions in mitochondria. I. General properties and nature of the products of succinate-linked reduction of pyridine nucleotide. J. Biol. Chem. 1961, 236:1534-1543.
18. Chen M., Zhang J., Manley J.L. Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA. Cancer Res. 2010, 70:8977-8980.
19. Cheng T., Sudderth J., Yang C., Mullen A.R., Jin E.S., Mates J.M., DeBerardinis R.J. Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:8674-8679.
20. Chesney J. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9:535-539.
21. Choi C., Ganji S.K., DeBerardinis R.J., Hatanpaa K.J., Rakheja D., Kovacs Z., Yang X.L., Mashimo T., Raisanen J.M., Marin-Valencia I., Pascual J.M., Madden C.J., Mickey B.E., Malloy C.R., Bachoo R.M., Maher E.A. 2-Hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat. Med. 2012, 18:624-629.
22. Christofk H.R., Vander Heiden M.G., Harris M.H., Ramanathan A., Gerszten R.E., Wei R., Fleming M.D., Schreiber S.L., Cantley L.C. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-233.
23. Costantini P., Chernyak B.V., Petronilli V., Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 1996, 271:6746-6751.
24. Dang L., White D.W., Gross S., Bennett B.D., Bittinger M.A., Driggers E.M., Fantin V.R., Jang H.G., Jin S., Keenan M.C., Marks K.M., Prins R.M., Ward P.S., Yen K.E., Liau L.M., Rabinowitz J.D., Cantley L.C., Thompson C.B., Vander Heiden M.G., Su S.M. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009, 462:739-744.
25. de la Rosa V., Campos-Sandoval J.A., Martin-Rufian M., Cardona C., Mates J.M., Segura J.A., Alonso F.J., Marquez J. A novel glutaminase isoform in mammalian tissues. Neurochem. Int. 2009, 55:76-84.
26. De Milito A., Fais S. Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol. 2005, 1:779-786.
27. Denko N.C. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 2008, 8:705-713.
28. Dong L.F., Low P., Dyason J.C., Wang X.F., Prochazka L., Witting P.K., Freeman R., Swettenham E., Valis K., Liu J., Zobalova R., Turanek J., Spitz D.R., Domann F.E., Scheffler I.E., Ralph S.J., Neuzil J. Alpha-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II. Oncogene 2008, 27:4324-4335.
29. Duncan C.G., Barwick B.G., Jin G., Rago C., Kapoor-Vazirani P., Powell D.R., Chi J.T., Bigner D.D., Vertino P.M., Yan H. A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation. Genome Res. 2012, 22:2339-2355.
30. Eagle H. Nutrition needs of mammalian cells in tissue culture. Science 1955, 122:501-514.
31. Elgadi K.M., Meguid R.A., Qian M., Souba W.W., Abcouwer S.F. Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol. Genomics 1999, 1:51-62.
32. Elkhaled A., Jalbert L.E., Phillips J.J., Yoshihara H.A., Parvataneni R., Srinivasan R., Bourne G., Berger M.S., Chang S.M., Cha S., Nelson S.J. Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas. Sci. Transl. Med. 2012, 4:116ra115.
33. Estrella V., Chen T., Lloyd M., Wojtkowiak J., Cornnell H.H., Ibrahim-Hashim A., Bailey K., Balagurunathan Y., Rothberg J.M., Sloane B.F., Johnson J., Gatenby R.A., Gillies R.J. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res. 2013, 73:1524-1535.
34. Fariss M.W., Nicholls-Grzemski F.A., Tirmenstein M.A., Zhang J.G. Enhanced antioxidant and cytoprotective abilities of vitamin E succinate is associated with a rapid uptake advantage in rat hepatocytes and mitochondria. Free Radic. Biol. Med. 2001, 31:530-541.
35. Ganapathy-Kanniappan S., Geschwind J.F., Kunjithapatham R., Buijs M., Vossen J.A., Tchernyshyov I., Cole R.N., Syed L.H., Rao P.P., Ota S., Vali M. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death. Anticancer Res. 2009, 29:4909-4918.
36. Gao P., Tchernyshyov I., Chang T.C., Lee Y.S., Kita K., Ochi T., Zeller K.I., De Marzo A.M., Van Eyk J.E., Mendell J.T., Dang C.V. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009, 458:762-765.
37. Gao X., Wang H., Yang J.J., Liu X., Liu Z.R. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol. Cell 2012, 45:598-609.
38. Geschwind J.F., Ko Y.H., Torbenson M.S., Magee C., Pedersen P.L. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res. 2002, 62:3909-3913.
39. Gleason C., Huang S., Thatcher L.F., Foley R.C., Anderson C.R., Carroll A.J., Millar A.H., Singh K.B. Mitochondrial complex II has a key role in mitochondrial-derived reactive oxygen species influence on plant stress gene regulation and defense. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:10768-10773.
40. 2+ release from mitochondria by respiratory substrates. Cell Calcium 1996, 19:521-526.
41. 2+ and ROS in alpha-tocopheryl succinate-induced mitochondrial permeabilization. Int. J. Cancer 2010, 127:1823-1832.
42. Gomez-Fabre P.M., Aledo J.C., Del Castillo-Olivares A., Alonso F.J., Nunez De Castro I., Campos J.A., Marquez J. Molecular cloning, sequencing and expression studies of the human breast cancer cell glutaminase. Biochem. J. 2000, 345(Pt 2):365-375.
43. Gottlieb E., Vander Heiden M.G., Thompson C.B. Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol. Cell. Biol. 2000, 20:5680-5689.
44. Grimm S. Respiratory chain complex II as general sensor for apoptosis. BBA-Bioenerg. 2013, 1827:565-572.
45. Halabe Bucay A. Hypothesis proved.citric acid (citrate) does improve cancer: a case of a patient suffering from medullary thyroid cancer. Med. Hypotheses 2009, 73:271.
46. Halestrap A.P. The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors. Biochem. J. 1975, 148:85-96.
47. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
48. Hanai J.I., Doro N., Seth P., Sukhatme V.P. ATP citrate lyase knockdown impacts cancer stem cells in vitro. Cell Death Dis. 2013, 4:e696.
49. Hartmann C., Meyer J., Balss J., Capper D., Mueller W., Christians A., Felsberg J., Wolter M., Mawrin C., Wick W., Weller M., Herold-Mende C., Unterberg A., Jeuken J.W., Wesseling P., Reifenberger G., von Deimling A. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1010 diffuse gliomas. Acta Neuropathol. 2009, 118:469-474.
50. Hassanein M., Hoeksema M.D., Shiota M., Qian J., Harris B.K., Chen H., Clark J.E., Alborn W.E., Eisenberg R., Massion P.P. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival. Clin. Cancer Res. 2013, 19:560-570.
51. Hatzivassiliou G., Zhao F., Bauer D.E., Andreadis C., Shaw A.N., Dhanak D., Hingorani S.R., Tuveson D.A., Thompson C.B. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 2005, 8:311-321.
52. Hillar M., Lott V., Lennox B. Correlation of the effects of citric acid cycle metabolites on succinate oxidation by rat liver mitochondria and submitochondrial particles. J. Bioenerg. 1975, 7:1-16.
53. Hobert J.A., Mester J.L., Moline J., Eng C. Elevated plasma succinate in PTEN, SDHB, and SDHD mutation-positive individuals. Genet. Med. 2012, 14:616-619.
54. Holleran A.L., Briscoe D.A., Fiskum G., Kelleher J.K. Glutamine metabolism in AS-30D hepatoma cells. Evidence for its conversion into lipids via reductive carboxylation. Mol. Cell. Biochem. 1995, 152:95-101.
55. Hoshino A., Hirst J.A., Fujii H. Regulation of cell proliferation by interleukin-3-induced nuclear translocation of pyruvate kinase. J. Biol. Chem. 2007, 282:17706-17711.
56. Hu W., Zhang C., Wu R., Sun Y., Levine A., Feng Z. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7455-7460.
57. Iacobazzi V., Infantino V., Palmieri F. Epigenetic mechanisms and Sp1 regulate mitochondrial citrate carrier gene expression. Biochem. Biophys. Res. Commun. 2008, 376:15-20.
58. Icard P., Poulain L., Lincet H. Understanding the central role of citrate in the metabolism of cancer cells. Biochim. Biophys. Acta 2012, 1825:111-116.
59. Ihrlund L.S., Hernlund E., Khan O., Shoshan M.C. 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs. Mol. Oncol. 2008, 2:94-101.
60. Infantino V., Convertini P., Cucci L., Panaro M.A., Di Noia M.A., Calvello R., Palmieri F., Iacobazzi V. The mitochondrial citrate carrier: a new player in inflammation. Biochem. J. 2011, 438:433-436.
61. Ishii T., Yasuda K., Akatsuka A., Hino O., Hartman P.S., Ishii N. A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. Cancer Res. 2005, 65:203-209.
62. Jiang B.H., Jiang G., Zheng J.Z., Lu Z., Hunter T., Vogt P.K. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ. 2001, 12:363-369.
63. Jurica M.S., Mesecar A., Heath P.J., Shi W., Nowak T., Stoddard B.L. The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate. Structure 1998, 6:195-210.
64. Kato M., Wynn R.M., Chuang J.L., Tso S.C., Machius M., Li J., Chuang D.T. Structural basis for inactivation of the human pyruvate dehydrogenase complex by phosphorylation: role of disordered phosphorylation loops. Structure 2008, 16:1849-1859.
65. Killian J.K., Kim S.Y., Miettinen M., Smith C., Merino M., Tsokos M., Quezado M., Smith W.I., Jahromi M.S., Xekouki P., Szarek E., Walker R.L., Lasota J., Raffeld M., Klotzle B., Wang Z., Jones L., Zhu Y., Wang Y., Waterfall J.J., O'Sullivan M.J., Bibikova M., Pacak K., Stratakis C., Janeway K.A., Schiffman J.D., Fan J.B., Helman L., Meltzer P.S. Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov. 2013, 3:648-657.
66. Kim J., DeBerardinis R.J. Cancer. Silencing a metabolic oncogene. Science 2013, 340:558-559.
67. Ko Y.H., Pedersen P.L., Geschwind J.F. Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett. 2001, 173:83-91.
68. 2+ uptake by mitochondria. Biochem. Biophys. Res. Commun. 1982, 109:376-381.
69. Kovarova J., Bajzikova M., Vondrusova M., Stursa J., Goodwin J., Nguyen M., Zobalova R., Pesdar E.A., Truksa J., Tomasetti M., Dong L.F., Neuzil J. Mitochondrial targeting of alpha-tocopheryl succinate enhances its anti-mesothelioma efficacy. Redox Rep. 2014, 19:16-25.
70. Kramer R., Palmieri F. Molecular aspects of isolated and reconstituted carrier proteins from animal mitochondria. Biochim. Biophys. Acta 1989, 974:1-23.
71. 18F]fluoroglutamic acid (BAY 85-8050), a new amino acid radiotracer for PET imaging of tumors: synthesis and in vitro characterization. J. Med. Chem. 2011, 54:406-410.
72. Krebs H.A., Eggleston L.V., D'Alessandro A. The effect of succinate and amytal on the reduction of acetoacetate in animal tissues. Biochem. J. 1961, 79:537-549.
73. Kruspig B., Nilchian A., Bejarano I., Orrenius S., Zhivotovsky B., Gogvadze V. Targeting mitochondria by alpha-tocopheryl succinate kills neuroblastoma cells irrespective of MycN oncogene expression. Cell. Mol. Life Sci. 2012, 69:2091-2099.
74. Kruspig B., Nilchian A., Orrenius S., Zhivotovsky B., Gogvadze V. Citrate kills tumor cells through activation of apical caspases. Cell. Mol. Life Sci. 2012, 69:4229-4237.
75. Kruspig B., Zhivotovsky B., Gogvadze V. Contrasting effects of alpha-tocopheryl succinate on cisplatin- and etoposide-induced apoptosis. Mitochondrion 2013, 13:533-538.
76. Kung H.N., Marks J.R., Chi J.T. Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia. PLoS Genet. 2011, 7:e1002229.
77. Le A., Lane A.N., Hamaker M., Bose S., Gouw A., Barbi J., Tsukamoto T., Rojas C.J., Slusher B.S., Zhang H., Zimmerman L.J., Liebler D.C., Slebos R.J., Lorkiewicz P.K., Higashi R.M., Fan T.W., Dang C.V. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 2012, 15:110-121.
78. Lee B.H., Tothova Z., Levine R.L., Anderson K., Buza-Vidas N., Cullen D.E., McDowell E.P., Adelsperger J., Frohling S., Huntly B.J., Beran M., Jacobsen S.E., Gilliland D.G. FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia. Cancer Cell 2007, 12:367-380.
79. Lee J., Kim H.K., Han Y.M., Kim J. Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription. Int. J. Biochem. Cell Biol. 2008, 40:1043-1054.
80. Lemarie A., Huc L., Pazarentzos E., Mahul-Mellier A.L., Grimm S. Specific disintegration of complex II succinate: ubiquinone oxidoreductase links pH changes to oxidative stress for apoptosis induction. Cell Death Differ. 2011, 18:338-349.
81. Lenaz G., Genova M.L. Mobility and function of coenzyme Q (ubiquinone) in the mitochondrial respiratory chain. Biochim. Biophys. Acta 2009, 1787:563-573.
82. Letouze E., Martinelli C., Loriot C., Burnichon N., Abermil N., Ottolenghi C., Janin M., Menara M., Nguyen A.T., Benit P., Buffet A., Marcaillou C., Bertherat J., Amar L., Rustin P., De Reynies A., Gimenez-Roqueplo A.P., Favier J. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell 2013, 23:739-752.
83. Lincet H., Kafara P., Giffard F., Abeilard-Lemoisson E., Duval M., Louis M.H., Poulain L., Icard P. Inhibition of Mcl-1 expression by citrate enhances the effect of Bcl-xL inhibitors on human ovarian carcinoma cells. J. Ovarian Res. 2013, 6:72.
84. Lobo C., Ruiz-Bellido M.A., Aledo J.C., Marquez J., Nunez De Castro I., Alonso F.J. Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells. Biochem. J. 2000, 348(Pt 2):257-261.
85. Lu Y., Zhang X., Zhang H., Lan J., Huang G., Varin E., Lincet H., Poulain L., Icard P. Citrate induces apoptotic cell death: a promising way to treat gastric carcinoma?. Anticancer Res. 2011, 31:797-805.
86. Lu C., Ward P.S., Kapoor G.S., Rohle D., Turcan S., Abdel-Wahab O., Edwards C.R., Khanin R., Figueroa M.E., Melnick A., Wellen K.E., O'Rourke D.M., Berger S.L., Chan T.A., Levine R.L., Mellinghoff I.K., Thompson C.B. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 2012, 483:474-478.
87. Luo W., Hu H., Chang R., Zhong J., Knabel M., O'Meally R., Cole R.N., Pandey A., Semenza G.L. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 2011, 145:732-744.
88. MacKenzie E.D., Selak M.A., Tennant D.A., Payne L.J., Crosby S., Frederiksen C.M., Watson D.G., Gottlieb E. Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol. Cell. Biol. 2007, 27:3282-3289.
89. Mardis E.R., Ding L., Dooling D.J., Larson D.E., McLellan M.D., Chen K., Koboldt D.C., Fulton R.S., Delehaunty K.D., McGrath S.D., Fulton L.A., Locke D.P., Magrini V.J., Abbott R.M., Vickery T.L., Reed J.S., Robinson J.S., Wylie T., Smith S.M., Carmichael L., Eldred J.M., Harris C.C., Walker J., Peck J.B., Du F., Dukes A.F., Sanderson G.E., Brummett A.M., Clark E., McMichael J.F., Meyer R.J., Schindler J.K., Pohl C.S., Wallis J.W., Shi X., Lin L., Schmidt H., Tang Y., Haipek C., Wiechert M.E., Ivy J.V., Kalicki J., Elliott G., Ries R.E., Payton J.E., Westervelt P., Tomasson M.H., Watson M.A., Baty J., Heath S., Shannon W.D., Nagarajan R., Link D.C., Walter M.J., Graubert T.A., DiPersio J.F., Wilson R.K., Ley T.J. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 2009, 361:1058-1066.
90. 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvate. Magn. Reson. Med. 2013, 69:1443-1450.
91. Metallo C.M., Gameiro P.A., Bell E.L., Mattaini K.R., Yang J., Hiller K., Jewell C.M., Johnson Z.R., Irvine D.J., Guarente L., Kelleher J.K., Vander Heiden M.G., Iliopoulos O., Stephanopoulos G. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 2012, 481:380-384.
92. Miettinen M., Wang Z.F., Sarlomo-Rikala M., Osuch C., Rutkowski P., Lasota J. Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am. J. Surg. Pathol. 2011, 35:1712-1721.
93. Moreno-Sanchez R., Hernandez-Esquivel L., Rivero-Segura N.A., Marin-Hernandez A., Neuzil J., Ralph S.J., Rodriguez-Enriquez S. Reactive oxygen species are generated by the respiratory complex II - evidence for lack of contribution of the reverse electron flow in complex I. FEBS J. 2013, 280:927-938.
94. Mullen A.R., Wheaton W.W., Jin E.S., Chen P.H., Sullivan L.B., Cheng T., Yang Y., Linehan W.M., Chandel N.S., DeBerardinis R.J. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 2012, 481:385-388.
95. Neuzil J., Massa H. Hepatic processing determines dual activity of alpha-tocopheryl succinate: a novel paradigm for a shift in biological activity due to pro-vitamin-to-vitamin conversion. Biochem. Biophys. Res. Commun. 2005, 327:1024-1027.
96. Neuzil J., Weber T., Gellert N., Weber C. Selective cancer cell killing by alpha-tocopheryl succinate. Br. J. Cancer 2001, 84:87-89.
97. Neuzil J., Weber T., Schroder A., Lu M., Ostermann G., Gellert N., Mayne G.C., Olejnicka B., Negre-Salvayre A., Sticha M., Coffey R.J., Weber C. Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements. FASEB J. 2001, 15:403-415.
98. Niemann S., Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat. Genet. 2000, 26:268-270.
99. Noguchi T., Inoue H., Tanaka T. The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J. Biol. Chem. 1986, 261:13807-13812.
100. Noguchi T., Yamada K., Inoue H., Matsuda T., Tanaka T. The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters. J. Biol. Chem. 1987, 262:14366-14371.
101. Nutt L.K., Margolis S.S., Jensen M., Herman C.E., Dunphy W.G., Rathmell J.C., Kornbluth S. Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2. Cell 2005, 123:89-103.
102. Nutt L.K., Buchakjian M.R., Gan E., Darbandi R., Yoon S.Y., Wu J.Q., Miyamoto Y.J., Gibbons J.A., Andersen J.L., Freel C.D., Tang W., He C., Kurokawa M., Wang Y., Margolis S.S., Fissore R.A., Kornbluth S. Metabolic control of oocyte apoptosis mediated by 14-3-3zeta-regulated dephosphorylation of caspase-2. Dev. Cell 2009, 16:856-866.
103. Parsons D.W., Jones S., Zhang X., Lin J.C., Leary R.J., Angenendt P., Mankoo P., Carter H., Siu I.M., Gallia G.L., Olivi A., McLendon R., Rasheed B.A., Keir S., Nikolskaya T., Nikolsky Y., Busam D.A., Tekleab H., Diaz L.A., Hartigan J., Smith D.R., Strausberg R.L., Marie S.K., Shinjo S.M., Yan H., Riggins G.J., Bigner D.D., Karchin R., Papadopoulos N., Parmigiani G., Vogelstein B., Velculescu V.E., Kinzler K.W. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-1812.
104. Pollyea D.A., Kohrt H.E., Zhang B., Zehnder J., Schenkein D., Fantin V., Straley K., Vasanthakumar A., Abdel-Wahab O., Levine R., Godley L.A., Medeiros B.C. 2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels. Leuk. Lymphoma 2013, 54:408-410.
105. Pop C., Fitzgerald P., Green D.R., Salvesen G.S. Role of proteolysis in caspase-8 activation and stabilization. Biochemistry 2007, 46:4398-4407.
106. Pope W.B., Prins R.M., Albert Thomas M., Nagarajan R., Yen K.E., Bittinger M.A., Salamon N., Chou A.P., Yong W.H., Soto H., Wilson N., Driggers E., Jang H.G., Su S.M., Schenkein D.P., Lai A., Cloughesy T.F., Kornblum H.I., Wu H., Fantin V.R., Liau L.M. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. J. Neuro-Oncol. 2012, 107:197-205.
107. Prasad K.N., Edwards-Prasad J. Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. Cancer Res. 1982, 42:550-555.
108. Prochazka L., Koudelka S., Dong L.F., Stursa J., Goodwin J., Neca J., Slavik J., Ciganek M., Masek J., Kluckova K., Nguyen M., Turanek J., Neuzil J. Mitochondrial targeting overcomes ABCA1-dependent resistance of lung carcinoma to alpha-tocopheryl succinate. Apoptosis 2013, 18:286-299.
109. Qie S., Chu C., Li W., Wang C., Sang N. ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation. J. Cell. Biochem. 2014, 115:498-509.
110. Qing G., Li B., Vu A., Skuli N., Walton Z.E., Liu X., Mayes P.A., Wise D.R., Thompson C.B., Maris J.M., Hogarty M.D., Simon M.C. ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. Cancer Cell 2012, 22:631-644.
111. Qu W., Zha Z., Ploessl K., Lieberman B.P., Zhu L., Wise D.R., Thompson C.B., Kung H.F. Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors. J. Am. Chem. Soc. 2011, 133:1122-1133.
112. Qu W., Oya S., Lieberman B.P., Ploessl K., Wang L., Wise D.R., Divgi C.R., Chodosh L.A., Thompson C.B., Kung H.F. Preparation and characterization of l-[5-11C]-glutamine for metabolic imaging of tumors. J. Nucl. Med. 2012, 53:98-105.
113. Quinlan C.L., Orr A.L., Perevoshchikova I.V., Treberg J.R., Ackrell B.A., Brand M.D. Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions. J. Biol. Chem. 2012, 287:27255-27264.
114. Ricci J.E., Gottlieb R.A., Green D.R. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J. Cell Biol. 2003, 160:65-75.
115. Ricketts C., Woodward E.R., Killick P., Morris M.R., Astuti D., Latif F., Maher E.R. Germline SDHB mutations and familial renal cell carcinoma. J. Natl. Cancer Inst. 2008, 100:1260-1262.
116. Rohle D., Popovici-Muller J., Palaskas N., Turcan S., Grommes C., Campos C., Tsoi J., Clark O., Oldrini B., Komisopoulou E., Kunii K., Pedraza A., Schalm S., Silverman L., Miller A., Wang F., Yang H., Chen Y., Kernytsky A., Rosenblum M.K., Liu W., Biller S.A., Su S.M., Brennan C.W., Chan T.A., Graeber T.G., Yen K.E., Mellinghoff I.K. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science 2013, 340:626-630.
117. Rose N.R., McDonough M.A., King O.N., Kawamura A., Schofield C.J. Inhibition of 2-oxoglutarate dependent oxygenases. Chem. Soc. Rev. 2011, 40:4364-4397.
118. Salas M.L., Vinuela E., Salas M., Sols A. Citrate inhibition of phosphofructokinase and the Pasteur effect. Biochem. Biophys. Res. Commun. 1965, 19:371-376.
119. Salvesen G.S., Dixit V.M. Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10964-10967.
120. Schafer Z.T., Grassian A.R., Song L., Jiang Z., Gerhart-Hines Z., Irie H.Y., Gao S., Puigserver P., Brugge J.S. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 2009, 461:109-113.
121. Schagger H., Pfeiffer K. Supercomplexes in the respiratory chains of yeast and mammalian mitochondria. EMBO J. 2000, 19:1777-1783.
122. Schodel J., Oikonomopoulos S., Ragoussis J., Pugh C.W., Ratcliffe P.J., Mole D.R. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 2011, 117:e207-e217.
123. Scott D.A., Richardson A.D., Filipp F.V., Knutzen C.A., Chiang G.G., Ronai Z.A., Osterman A.L., Smith J.W. Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect. J. Biol. Chem. 2011, 286:42626-42634.
124. Selak M.A., Armour S.M., MacKenzie E.D., Boulahbel H., Watson D.G., Mansfield K.D., Pan Y., Simon M.C., Thompson C.B., Gottlieb E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005, 7:77-85.
125. Semenza G.L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010, 29:625-634.
126. Shapiro R.A., Farrell L., Srinivasan M., Curthoys N.P. Isolation, characterization, and in vitro expression of a cDNA that encodes the kidney isoenzyme of the mitochondrial glutaminase. J. Biol. Chem. 1991, 266:18792-18796.
127. Sies H., Summer K.H. Hydroperoxide-metabolizing systems in rat liver. Eur. J. Biochem. 1975, 57:503-512.
128. Smith E.M., Watford M. Molecular cloning of a cDNA for rat hepatic glutaminase. Sequence similarity to kidney-type glutaminase. J. Biol. Chem. 1990, 265:10631-10636.
129. Stapelberg M., Tomasetti M., Alleva R., Gellert N., Procopio A., Neuzil J. α-Tocopheryl succinate inhibits proliferation of mesothelioma cells by selective down-regulation of fibroblast growth factor receptors. Biochem. Biophys. Res. Commun. 2004, 318:636-641.
130. Stetak A., Veress R., Ovadi J., Csermely P., Keri G., Ullrich A. Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death. Cancer Res. 2007, 67:1602-1608.
131. Sun R.C., Denko N.C. Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth. Cell Metab. 2014, 19:285-292.
132. Sun F., Huo X., Zhai Y., Wang A., Xu J., Su D., Bartlam M., Rao Z. Crystal structure of mitochondrial respiratory membrane protein complex II. Cell 2005, 121:1043-1057.
133. Sun Q., Chen X., Ma J., Peng H., Wang F., Zha X., Wang Y., Jing Y., Yang H., Chen R., Chang L., Zhang Y., Goto J., Onda H., Chen T., Wang M.R., Lu Y., You H., Kwiatkowski D., Zhang H. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:4129-4134.
134. Suzuki S., Tanaka T., Poyurovsky M.V., Nagano H., Mayama T., Ohkubo S., Lokshin M., Hosokawa H., Nakayama T., Suzuki Y., Sugano S., Sato E., Nagao T., Yokote K., Tatsuno I., Prives C. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7461-7466.
135. Swettenham E., Witting P.K., Salvatore B.A., Neuzil J. Alpha-tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: potential therapy of malignancies of the nervous system?. J. Neurochem. 2005, 94:1448-1456.
136. Szeliga M., Sidoryk M., Matyja E., Kowalczyk P., Albrecht J. Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas. Neurosci. Lett. 2005, 374:171-173.
137. Szeliga M., Obara-Michlewska M., Matyja E., Lazarczyk M., Lobo C., Hilgier W., Alonso F.J., Marquez J., Albrecht J. Transfection with liver-type glutaminase cDNA alters gene expression and reduces survival, migration and proliferation of T98G glioma cells. Glia 2009, 57:1014-1023.
138. Tannahill G.M., Curtis A.M., Adamik J., Palsson-McDermott E.M., McGettrick A.F., Goel G., Frezza C., Bernard N.J., Kelly B., Foley N.H., Zheng L., Gardet A., Tong Z., Jany S.S., Corr S.C., Haneklaus M., Caffrey B.E., Pierce K., Walmsley S., Beasley F.C., Cummins E., Nizet V., Whyte M., Taylor C.T., Lin H., Masters S.L., Gottlieb E., Kelly V.P., Clish C., Auron P.E., Xavier R.J., O'Neill L.A. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature 2013, 496:238-242.
139. Taylor W.M., Halperin M.L. Regulation of pyruvate dehydrogenase in muscle. Inhibition by citrate. J. Biol. Chem. 1973, 248:6080-6083.
140. Tennant D.A., Frezza C., MacKenzie E.D., Nguyen Q.D., Zheng L., Selak M.A., Roberts D.L., Dive C., Watson D.G., Aboagye E.O., Gottlieb E. Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death. Oncogene 2009, 28:4009-4021.
141. Thangaraju M., Karunakaran S.K., Itagaki S., Gopal E., Elangovan S., Prasad P.D., Ganapathy V. Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate. Cancer 2009, 115:4655-4666.
142. Turcan S., Rohle D., Goenka A., Walsh L.A., Fang F., Yilmaz E., Campos C., Fabius A.W., Lu C., Ward P.S., Thompson C.B., Kaufman A., Guryanova O., Levine R., Heguy A., Viale A., Morris L.G., Huse J.T., Mellinghoff I.K., Chan T.A. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 2012, 483:479-483.
143. van den Heuvel A.P., Jing J., Wooster R.F., Bachman K.E. Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth. Cancer Biol. Ther. 2012, 13:1185-1194.
144. Vander Heiden M.G., Chandel N.S., Schumacker P.T., Thompson C.B. Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol. Cell 1999, 3:159-167.
145. Vaughn A.E., Deshmukh M. Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat. Cell Biol. 2008, 10:1477-1483.
146. Wang J.B., Erickson J.W., Fuji R., Ramachandran S., Gao P., Dinavahi R., Wilson K.F., Ambrosio A.L., Dias S.M., Dang C.V., Cerione R.A. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 2010, 18:207-219.
147. Wang F., Travins J., DeLaBarre B., Penard-Lacronique V., Schalm S., Hansen E., Straley K., Kernytsky A., Liu W., Gliser C., Yang H., Gross S., Artin E., Saada V., Mylonas E., Quivoron C., Popovici-Muller J., Saunders J.O., Salituro F.G., Yan S., Murray S., Wei W., Gao Y., Dang L., Dorsch M., Agresta S., Schenkein D.P., Biller S.A., Su S.M., de Botton S., Yen K.E. Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation. Science 2013, 340:622-626.
148. Wang H.J., Hsieh Y.J., Cheng W.C., Lin C.P., Lin Y.S., Yang S.F., Chen C.C., Izumiya Y., Yu J.S., Kung H.J., Wang W.C. JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1alpha-mediated glucose metabolism. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:279-284.
149. Warburg O., Wind F., Negelein E. The metabolism of tumors in the body. J. Gen. Physiol. 1927, 8:519-530.
150. Ward P.S., Patel J., Wise D.R., Abdel-Wahab O., Bennett B.D., Coller H.A., Cross J.R., Fantin V.R., Hedvat C.V., Perl A.E., Rabinowitz J.D., Carroll M., Su S.M., Sharp K.A., Levine R.L., Thompson C.B. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 2010, 17:225-234.
151. Waygood E.B., Sanwal B.D. Regulation of pyruvate kinases by succinyl coenzyme A. Biochem. Biophys. Res. Commun. 1972, 48:402-407.
152. Waygood E.B., Sanwal B.D. The control of pyruvate kinases of Escherichia coli. I. Physicochemical and regulatory properties of the enzyme activated by fructose 1,6-diphosphate. J. Biol. Chem. 1974, 249:265-274.
153. Wise D.R., Thompson C.B. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem. Sci. 2010, 35:427-433.
154. Wise D.R., DeBerardinis R.J., Mancuso A., Sayed N., Zhang X.Y., Pfeiffer H.K., Nissim I., Daikhin E., Yudkoff M., McMahon S.B., Thompson C.B. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:18782-18787.
155. Wise D.R., Ward P.S., Shay J.E., Cross J.R., Gruber J.J., Sachdeva U.M., Platt J.M., DeMatteo R.G., Simon M.C., Thompson C.B. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:19611-19616.
156. Wong N., Ojo D., Yan J., Tang D. PKM2 contributes to cancer metabolism. Cancer Lett. 2014, (Epub ahead of print, PMID: 24508027).
157. Wouters B.G., Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat. Rev. Cancer 2008, 8:851-864.
158. Xiao M., Yang H., Xu W., Ma S., Lin H., Zhu H., Liu L., Liu Y., Yang C., Xu Y., Zhao S., Ye D., Xiong Y., Guan K.L. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 2012, 26:1326-1338.
159. Xu W., Yang H., Liu Y., Yang Y., Wang P., Kim S.H., Ito S., Yang C., Wang P., Xiao M.T., Liu L.X., Jiang W.Q., Liu J., Zhang J.Y., Wang B., Frye S., Zhang Y., Xu Y.H., Lei Q.Y., Guan K.L., Zhao S.M., Xiong Y. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 2011, 19:17-30.
160. Yalcin A., Clem B.F., Simmons A., Lane A., Nelson K., Clem A.L., Brock E., Siow D., Wattenberg B., Telang S., Chesney J. Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J. Biol. Chem. 2009, 284:24223-24232.
161. Yalcin A., Telang S., Clem B., Chesney J. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. Exp. Mol. Pathol. 2009, 86:174-179.
162. Yan H., Parsons D.W., Jin G., McLendon R., Rasheed B.A., Yuan W., Kos I., Batinic-Haberle I., Jones S., Riggins G.J., Friedman H., Friedman A., Reardon D., Herndon J., Kinzler K.W., Velculescu V.E., Vogelstein B., Bigner D.D. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 2009, 360:765-773.
163. Yang C., Sudderth J., Dang T., Bachoo R.M., McDonald J.G., DeBerardinis R.J. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res. 2009, 69:7986-7993.
164. Yang W., Xia Y., Ji H., Zheng Y., Liang J., Huang W., Gao X., Aldape K., Lu Z. Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature 2011, 480:118-122.
165. Yang W., Xia Y., Cao Y., Zheng Y., Bu W., Zhang L., You M.J., Koh M.Y., Cote G., Aldape K., Li Y., Verma I.M., Chiao P.J., Lu Z. EGFR-induced and PKCepsilon monoubiquitylation-dependent NF-kappaB activation upregulates PKM2 expression and promotes tumorigenesis. Mol. Cell 2012, 48:771-784.
166. Yi C.H., Sogah D.K., Boyce M., Degterev A., Christofferson D.E., Yuan J. A genome-wide RNAi screen reveals multiple regulators of caspase activation. J. Cell Biol. 2007, 179:619-626.
167. Yi C.H., Pan H., Seebacher J., Jang I.H., Hyberts S.G., Heffron G.J., Vander Heiden M.G., Yang R., Li F., Locasale J.W., Sharfi H., Zhai B., Rodriguez-Mias R., Luithardt H., Cantley L.C., Daley G.Q., Asara J.M., Gygi S.P., Wagner G., Liu C.F., Yuan J. Metabolic regulation of protein N-alpha-acetylation by Bcl-xL promotes cell survival. Cell 2011, 146:607-620.
168. Yousefi S., Owens J.W., Cesario T.C. Citrate shows specific, dose-dependent lympholytic activity in neoplastic cell lines. Leuk. Lymphoma 2004, 45:1657-1665.
169. Yuneva M., Zamboni N., Oefner P., Sachidanandam R., Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J. Cell Biol. 2007, 178:93-105.
170. Zhang X., Varin E., Allouche S., Lu Y., Poulain L., Icard P. Effect of citrate on malignant pleural mesothelioma cells: a synergistic effect with cisplatin. Anticancer Res. 2009, 29:1249-1254.